“Clinical trials show that it is an effective solution to prevent the spread of the infection,” they say from Russia.
Barely 48 hours after the US pharmaceutical company Pfizer confirmed that its vaccine against the coronavirus was 90% effective, they announced another major novelty from Russia to stop the pandemic: the Sputnik V vaccine reached 92% effectiveness in its first phase three trials.
“The efficacy of the Sputnik V vaccine reached 92% efficacy. Currently, 40,000 volunteers are participating in phase III, double-blind, randomized, placebo-controlled clinical trials, of which more than 20,000 have been vaccinated with the first dose of the vaccine and more than 16,000 with both the 1st and 2nd doses of the vaccine. vaccine” reported the Gamaleya National Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF).
After 42 days, the Gamaleya Center and the Russian Direct Investment Fund (FIDR) assured that after the second round of testing, vaccine efficacy reached 95%, the highest ratio to date.
In turn, Russian Health Minister Mikhail Murashko was also very optimistic about the coming months: “The use of the vaccine and the results of clinical trials show that it is an effective solution to stop the spread of coronavirus infection and a preventative health care tool… This is the most successful way to beat the pandemic.”
What will the distribution be like?
Gamaleya Center director Alexander Gintsburg reported that, “Thanks to increased production from the new production sites, the Sputnik V vaccine will soon be available to a wider population.” Kirill Dmitriev, executive director of RDIF, argued that more than 1.2 billion doses of the Sputnik V vaccine have already been requested from more than 50 countries.
Salvador Illa, Minister of Health, has already set a date for the start of vaccination in Spain. “Vaccination in Spain will begin on December 27 after we received the first doses of the Pfizer vaccine the day before. Weekly doses will be received that will be distributed equitably among the Autonomous Communities and administered as determined in the national strategy. is the beginning of the end of the pandemic, but it is not the end. We will have to continue to take measures and continue to take responsibility,” says Illa.
About 500 thousand doses in November
Sputnik V administered in two phases , with an interval of 21 days and consists of two components: the first is based on human adenovirus type 26; and the second, in recombinant human adenovirus type 5. Russia will produce about 500,000 doses of the vaccine in November.
Source: Goal